Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Enterprise Value (2016 - 2026)

Surgery Partners (SGRY) has disclosed Enterprise Value for 13 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 3.63% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, up 3.63% year-over-year, with the annual reading at $1.2 billion for FY2025, 3.63% up from the prior year.
  • Enterprise Value hit $1.2 billion in Q4 2025 for Surgery Partners, down from $1.2 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $1.2 billion in Q3 2025 to a low of -$233.7 million in Q1 2021.
  • Historically, Enterprise Value has averaged $339.2 million across 5 years, with a median of $135.0 million in 2023.
  • Biggest five-year swings in Enterprise Value: plummeted 1210.34% in 2021 and later surged 1020.0% in 2022.
  • Year by year, Enterprise Value stood at -$59.7 million in 2021, then skyrocketed by 198.99% to $59.1 million in 2022, then surged by 122.5% to $131.5 million in 2023, then skyrocketed by 764.79% to $1.1 billion in 2024, then rose by 3.63% to $1.2 billion in 2025.
  • Business Quant data shows Enterprise Value for SGRY at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.